NCLEX-style practice question
A nurse is explaining the FDA drug approval process to a client's family. Which statement by the nurse is most accurate about the evidence the FDA generally expects from a drug manufacturer?
- One well-designed clinical trial is always sufficient for approval.
- Results from two well-designed clinical trials are generally expected so that findings are not due to chance or bias.
- Animal studies are sufficient evidence of safety and effectiveness in humans.
- Clinical trials are only required after the drug has been sold to the public.
Show answer and rationale
Correct answer: B. Results from two well-designed clinical trials are generally expected so that findings are not due to chance or bias.
The FDA generally expects two well-designed clinical trials so findings from the first are not due to chance or bias, though one trial may suffice for rare diseases where multiple trials are not feasible. Animal testing is done before human trials and does not replace them. Clinical trials occur before approval, not after sale.
Adapted from Open RN Nursing Pharmacology, Chippewa Valley Technical College, CC BY 4.0.
Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies